Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes
Recent cancer molecular therapies are targeting main functional molecules to control applicable process of cancer cells. Attractive targets are established by receptor tyrosine kinases, such as platelet-derived growth factor receptors (PDGFRs) and c-Kit as mostly irregular signaling, which is due to...
Main Authors: | Kadivar, A., Kamalidehghan, B., Javar, H.A., Karimi, B., Sedghi, R., Noordin, M.I. |
---|---|
Format: | Article |
Published: |
Dove Medical Press
2017
|
Subjects: |
Similar Items
-
Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression
by: Kadivar, Ali, et al.
Published: (2018) -
[Corrigendum] Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression
by: Kadivar, Ali, et al.
Published: (2019) -
Effects of zinc supplement on tumorigenic (MCF-7) and non-tumorigenic (MCF-10A) mammary epithelial cells under different oxygen conditions
by: Lee, Sze Yen
Published: (2013) -
Molecular basis of primary and secondary
resistance to imatinib mesylate
by: Abdul Aziz, Baba
Published: (2012) -
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis.
by: Cao, R, et al.
Published: (2004)